Cancer BiologybioRxiv
APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer
H. Isozaki, A. Abbasi, N. Nikpour…·A. N. Hata
This study shows that APOBEC3A mutagenesis driven by targeted therapies promotes drug resistance in non-small cell lung cancer.
DOI 10.1038/s41586-023-06303-1